HGERS
XENE icon

Householder Group Estate & Retirement Specialist’s Xenon Pharmaceuticals XENE Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-215
Closed -$9.26K – 1353
2024
Q1 		$9.26K Hold
215
– – ﹤0.01% 827
2023
Q4 		$9K Sell
215
-68
-24% -$2.4K ﹤0.01% 799
2023
Q3 		$9.67K Buy
+283
New +$10.6K ﹤0.01% 797
2023
Q1 		$10K Buy
283
+8
+3% +$296 ﹤0.01% 819
2022
Q4 		$10K Hold
275
– – 0.01% 228
2022
Q3 		$9K Buy
+275
New +$9.89K ﹤0.01% 768

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's XENE Position: Q2 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Xenon Pharmaceuticals (XENE) in Q2 2024, closing a stake of 215 shares — an estimated $9.26K sold.

Householder Group Estate & Retirement Specialist first reported a position in XENE in Q3 2022 and held it in 6 quarters. The position peaked at $10K in Q1 2023. 213 funds tracked by Wall St. Rank hold XENE as of Q2 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Xenon Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 215 Xenon Pharmaceuticals shares in Q2 2024, an estimated $9.26K.
  • Householder Group Estate & Retirement Specialist first reported a position in Xenon Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Householder Group Estate & Retirement Specialist's Xenon Pharmaceuticals position peaked at $10K in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q2 2024, filed 17 Jul 2024.